Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Moonlake Immunotherapeutics Class A Ordinary Shares | MLTX

AI Analysis of Moonlake Immunotherapeutics Class A Ordinary Shares

Moonlake Immunotherapeutics Ordinary Shares is up a bit on the day, funds flowing in kept the price up 2.22% since yesterday. It looks like MLTX may be interacting with an upward sloping support line. These can create nice entry points since it can have both momentum and support. In addition to being near an angled support line MLTX is near a moderate strength horizontal support line. This represents a potential pivot point where the price might find support and move upward. But it can also break through this line in which case there might be a burst of selling on the other side. Moonlake Immunotherapeutics Ordinary Shares hasn't been that impressive in terms of its 3 month momentum, we'll see if it can turn things around and start heading up or continue its slide down.

If the price bounces off of the support and moves up it'll probably head up to the $22.16 level, at which point it may hit some selling pressure. There aren't very obvious support levels beneath this point. So put those stop losses on, this thing has room to fall if buyers don't come in at this level.


Last analyzed on 2026-07-23

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-